Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1902 1
1910 1
1917 2
1921 1
1928 1
1931 1
1934 1
1939 3
1940 5
1941 1
1942 1
1943 2
1945 3
1946 16
1947 15
1948 13
1949 5
1950 16
1951 18
1952 22
1953 14
1954 19
1955 14
1956 25
1957 13
1958 18
1959 26
1960 15
1961 21
1962 16
1963 14
1964 25
1965 32
1966 27
1967 34
1968 42
1969 46
1970 41
1971 49
1972 44
1973 58
1974 66
1975 89
1976 73
1977 70
1978 88
1979 80
1980 93
1981 96
1982 106
1983 101
1984 106
1985 135
1986 129
1987 137
1988 129
1989 158
1990 177
1991 180
1992 182
1993 224
1994 212
1995 271
1996 247
1997 258
1998 258
1999 258
2000 246
2001 282
2002 288
2003 282
2004 331
2005 350
2006 371
2007 435
2008 454
2009 478
2010 531
2011 492
2012 510
2013 521
2014 580
2015 564
2016 576
2017 645
2018 588
2019 604
2020 189
Text availability
Article attribute
Article type
Publication date

Search Results

12,988 results
Results by year
Filters applied: . Clear all
Page 1
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma.
Wolf Y, Bartok O, Patkar S, Eli GB, Cohen S, Litchfield K, Levy R, Jiménez-Sánchez A, Trabish S, Lee JS, Karathia H, Barnea E, Day CP, Cinnamon E, Stein I, Solomon A, Bitton L, Pérez-Guijarro E, Dubovik T, Shen-Orr SS, Miller ML, Merlino G, Levin Y, Pikarsky E, Eisenbach L, Admon A, Swanton C, Ruppin E, Samuels Y. Wolf Y, et al. Among authors: Miller ML. Cell. 2019 Sep 19;179(1):219-235.e21. doi: 10.1016/j.cell.2019.08.032. Epub 2019 Sep 12. Cell. 2019. PMID: 31522890 Free PMC article.
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer.
Formisano L, Lu Y, Servetto A, Hanker AB, Jansen VM, Bauer JA, Sudhan DR, Guerrero-Zotano AL, Croessmann S, Guo Y, Ericsson PG, Lee KM, Nixon MJ, Schwarz LJ, Sanders ME, Dugger TC, Cruz MR, Behdad A, Cristofanilli M, Bardia A, O'Shaughnessy J, Nagy RJ, Lanman RB, Solovieff N, He W, Miller M, Su F, Shyr Y, Mayer IA, Balko JM, Arteaga CL. Formisano L, et al. Among authors: Miller M. Nat Commun. 2019 Mar 26;10(1):1373. doi: 10.1038/s41467-019-09068-2. Nat Commun. 2019. PMID: 30914635 Free PMC article.
History of Amusia.
Kawamura M, Miller MW. Kawamura M, et al. Among authors: Miller MW. Front Neurol Neurosci. 2019;44:83-88. doi: 10.1159/000494955. Epub 2019 Apr 30. Front Neurol Neurosci. 2019. PMID: 31220839 Review.
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Petrakova K, Blackwell KL, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Mondal S, Su F, Miller M, Elmeliegy M, Germa C, O'Shaughnessy J. Hortobagyi GN, et al. Among authors: Miller M. Ann Oncol. 2019 Nov 1;30(11):1842. doi: 10.1093/annonc/mdz215. Ann Oncol. 2019. PMID: 31407010 Free PMC article. No abstract available.
Passenger Hotspot Mutations in Cancer.
Hess JM, Bernards A, Kim J, Miller M, Taylor-Weiner A, Haradhvala NJ, Lawrence MS, Getz G. Hess JM, et al. Among authors: Miller M. Cancer Cell. 2019 Sep 16;36(3):288-301.e14. doi: 10.1016/j.ccell.2019.08.002. Cancer Cell. 2019. PMID: 31526759
Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression.
Lama L, Adura C, Xie W, Tomita D, Kamei T, Kuryavyi V, Gogakos T, Steinberg JI, Miller M, Ramos-Espiritu L, Asano Y, Hashizume S, Aida J, Imaeda T, Okamoto R, Jennings AJ, Michino M, Kuroita T, Stamford A, Gao P, Meinke P, Glickman JF, Patel DJ, Tuschl T. Lama L, et al. Among authors: Miller M. Nat Commun. 2019 May 21;10(1):2261. doi: 10.1038/s41467-019-08620-4. Nat Commun. 2019. PMID: 31113940 Free PMC article.
Clinical Utility of Advanced Microbiology Testing Tools.
Miller MB, Atrzadeh F, Burnham CA, Cavalieri S, Dunn J, Jones S, Mathews C, McNult P, Meduri J, Newhouse C, Newton D, Oberholzer M, Osiecki J, Pedersen D, Sweeney N, Whitfield N, Campos J; ASM Clinical and Public Health Microbiology Committee and the ASM Corporate Council. Miller MB, et al. J Clin Microbiol. 2019 Aug 26;57(9):e00495-19. doi: 10.1128/JCM.00495-19. Print 2019 Sep. J Clin Microbiol. 2019. PMID: 31217268 Free PMC article. Review.
Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis.
Huang M, Tailor J, Zhen Q, Gillmor AH, Miller ML, Weishaupt H, Chen J, Zheng T, Nash EK, McHenry LK, An Z, Ye F, Takashima Y, Clarke J, Ayetey H, Cavalli FMG, Luu B, Moriarity BS, Ilkhanizadeh S, Chavez L, Yu C, Kurian KM, Magnaldo T, Sevenet N, Koch P, Pollard SM, Dirks P, Snyder MP, Largaespada DA, Cho YJ, Phillips JJ, Swartling FJ, Morrissy AS, Kool M, Pfister SM, Taylor MD, Smith A, Weiss WA. Huang M, et al. Among authors: Miller ML. Version 2. Cell Stem Cell. 2019 Sep 5;25(3):433-446.e7. doi: 10.1016/j.stem.2019.05.013. Epub 2019 Jun 13. Cell Stem Cell. 2019. PMID: 31204176 Free PMC article.
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
Skulas-Ray AC, Wilson PWF, Harris WS, Brinton EA, Kris-Etherton PM, Richter CK, Jacobson TA, Engler MB, Miller M, Robinson JG, Blum CB, Rodriguez-Leyva D, de Ferranti SD, Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Skulas-Ray AC, et al. Among authors: Miller M. Circulation. 2019 Sep 17;140(12):e673-e691. doi: 10.1161/CIR.0000000000000709. Epub 2019 Aug 19. Circulation. 2019. PMID: 31422671
12,988 results
Jump to page
Feedback